APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04858334

Title field or adapter rule

{'original_value': 'APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:22.066538+00:00

Published At

2026-10-26T00:00:00+00:00

Record Updated At

2026-10-26

Source Retrieved At

2026-10-31T22:17:25.750886+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Acinar Cell Carcinoma", "Pancreatic Adenosquamous Carcinoma", "Pancreatic Squamous Cell Carcinoma", "Resectable Pancreatic Acinar Cell Carcinoma", "Resectable Pancreatic Adenocarcinoma", "Resectable Pancreatic Adenosquamous Carcinoma", "Resectable Pancreatic Carcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-26", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT04858334"

protocolSection.identificationModule.officialTitle

"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Acinar Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Pancreatic Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
• Pancreatic Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Resectable Pancreatic Acinar Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Resectable Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Resectable Pancreatic Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
• Resectable Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Arm I (olaparib)', 'Arm II (placebo)'], 'description': 'Undergo collection of blood', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm I (olaparib)', 'Arm II (placebo)'], 'description': 'Undergo CT or CT/MRI', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm I (olaparib)', 'Arm II (placebo)'], 'description': 'Undergo CT/MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm I (olaparib)'], 'description': 'Given PO', 'name': 'Olaparib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm II (placebo)'], 'description': 'Given PO', 'name': 'Placebo Administration', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Olaparib (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo Administration (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.